Clinical Trial Update: Antihypertensive Response to Losartan and Genetic Polymorphisms [NA]

View source ↗

Summary

A completed clinical trial update examining how genetic polymorphisms influence the antihypertensive response to losartan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypertension | NA | Status: COMPLETED